2024 Future Healthcare Top Equity Investment Institutions and Best Practice Cases Announced by VB100

Amid the diversified development of the global economy, the healthcare industry continues to demonstrate robust growth momentum, driven by its unique resilience and potential, thereby becoming one of the key pillars of the global economy. According to forecasts by market research firms, the global healthcare market size is projected to reach trillions of U.S. dollars by 2024. Technological innovation and capital empowerment serve as the core engines propelling the rapid expansion of this industry.

Building on the 2023 Future Healthcare Equity Investment Selection Awards, VCBeat continues to launch“2024 Future Healthcare Equity Investment Awards”, aiming to establish benchmarks and exemplars for equity investment in the primary healthcare market through this selection process, guide investment institutions to focus on the long-term development value of the healthcare industry, and promote innovation, upgrading, and high-quality growth within the sector. Meanwhile, it also provides important references and insights for stakeholders both inside and outside the industry, helping investors, entrepreneurs, practitioners, and other key players in the healthcare sector better grasp market dynamics and industry trends.

Following a one-month period of database review and targeted research with frontline institutions, we have finalized the selection of the “Top 50 Best Equity Investment Institutions in Future Healthcare for 2024,” while also identifying five representative cases each in investment, exit, and value-added empowerment. Based on this Top 50 selection, we also aim to collaborate with the selected institutions to establishVB50 Fund Think Tank, Co-building 2025Top 100 Future Healthcare and Pharmaceutical ConferenceEcosystem and 2025 Future Healthcare Top 100 Selection.

1. The evaluation model for the “Top 50 Best Equity Investment Firms in Future Healthcare 2024” conducts a comprehensive assessment across four dimensions: industry investment performance (80%), industry influence (10%), innovation capability, and social responsibility and sustainable development (10%). Among these, industry investment performance serves as the core dimension of the evaluation model, with a primary focus on the scale of investments made by firms in the healthcare sector, measured by the number of deals and total investment amount.

2. The “Top 50 Best Equity Investment Institutions in Future Healthcare 2024” is an industry-specific selection initiative focused on the healthcare sector. It does not categorize institutions by investment stage (e.g., early-stage, VC, PE). Given the significant differences among institutions in terms of investment stage, strategy, and capital deployed, no ranked ordering was applied. Instead, institutions are presented in two tiers—Top 20 and Top 50—based on comprehensive evaluation.

3. The data for the selection of the Top 50 Best Equity Investment Firms in Future Healthcare and Health (2024) is sourced from institutional records archived by VBInsight, the industry think tank of VCBeat, as well as from institutional data collected through industry surveys. Certain firms were excluded from the evaluation due to missing data resulting from non-disclosure of investment figures (and thus not being archived) or non-participation in industry surveys.

4. 2024 Best Investment Performance Case in Future Healthcare: Focuses on the growth potential of the investment project, performance across the entire investment process, and industry recognition. 2024 Best Exit Performance Case in Future Healthcare: Focuses on exit returns, performance across the entire investment and exit process, and industry recognition. 2024 Best Exit Empowerment Case in Future Healthcare: Focuses on performance across the entire process of industrial empowerment for the investment project and industry recognition.

VB50 Fund Think Tank (Preparatory), hereinafter referred to as VB50, was initiated by VCBeat VB100. It brings together China’s top healthcare investment institutions and is committed to deeply exploring the potential and value of the healthcare industry through resource sharing, experience exchange, and joint research, thereby contributing to the transformation, upgrading, and high-quality development of the Future Healthcare & Pharmaceutical Top 100 Conference and its rankings. The founding members of VB50 will comprise the Top 50 Equity Investment Institutions in Future Healthcare for 2024, who are invited to co-build the 9th Future Healthcare & Pharmaceutical Top 100 Conference in 2025 and the 2025 9th Future Healthcare 100 selection.

In terms of conference co-creation, VB50 member organizations will serve as domain partners to jointly build an ecosystem that aggregates top-tier industry resources, delivers forward-looking industry value, and showcases the latest industry products. This initiative aims to foster exchange and collaboration among various stakeholders in the healthcare industry, jointly explore new opportunities and challenges, and drive continuous innovation and upgrading of the sector. Meanwhile, VB50 member organizations will also act as review experts, deeply participating in the 2025 9th Future Healthcare 100 Selection. They will recommend experts to engage throughout the entire evaluation process and nominate high-quality projects for consideration, thereby ensuring the fairness, authority, and forward-looking nature of the selection results.

Looking ahead, VB50 Fund Think Tank will continue to uphold the principles of openness, collaboration, and mutual benefit. By joining forces with investment stakeholders across the healthcare industry, we aim to pioneer a new chapter in equity investment for healthcare and contribute our expertise and strength to fostering the prosperous development of the global healthcare sector.